In the latest session, Clene Inc (NASDAQ: CLNN) closed at $0.43 up 0.09% from its previous closing price of $0.43. In other words, the price has increased by $+0.0004 from its previous closing price. On the day, 238275 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
For a deeper understanding of Clene Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.53 and its Current Ratio is at 1.53. In the meantime, Its Debt-to-Equity ratio is 2.40 whereas as Long-Term Debt/Eq ratio is at 0.90.
On July 18, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $16.
On May 02, 2022, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $10.Canaccord Genuity initiated its Buy rating on May 02, 2022, with a $10 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 10 ’23 when MATLIN DAVID J bought 250,002 shares for $0.41 per share. The transaction valued at 102,501 led to the insider holds 7,043,686 shares of the business.
Stevens John Henry bought 316,455 shares of CLNN for $253,164 on Jun 26 ’23. The Director now owns 800,204 shares after completing the transaction at $0.80 per share. On Jun 26 ’23, another insider, Etherington Robert Dee, who serves as the Chief Executive Officer of the company, bought 25,000 shares for $0.81 each. As a result, the insider paid 20,250 and bolstered with 25,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLNN now has a Market Capitalization of 54.58M and an Enterprise Value of 51.74M. For the stock, the TTM Price-to-Sale (P/S) ratio is 84.05 while its Price-to-Book (P/B) ratio in mrq is 4.08. Its current Enterprise Value per Revenue stands at 79.12 whereas that against EBITDA is -1.20.
Stock Price History:
Over the past 52 weeks, CLNN has reached a high of $1.22, while it has fallen to a 52-week low of $0.25. The 50-Day Moving Average of the stock is 0.4446, while the 200-Day Moving Average is calculated to be 0.5502.
Shares Statistics:
For the past three months, CLNN has traded an average of 864.95K shares per day and 377.42k over the past ten days. A total of 128.42M shares are outstanding, with a floating share count of 67.95M. Insiders hold about 47.09% of the company’s shares, while institutions hold 9.06% stake in the company. Shares short for CLNN as of Mar 15, 2024 were 262.48k with a Short Ratio of 0.30, compared to 228.73k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.20% and a Short% of Float of 0.27%.
Earnings Estimates
There are 5 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.08 for the current quarter, with a high estimate of -$0.06 and a low estimate of -$0.09, while EPS last year was -$0.15. The consensus estimate for the next quarter is -$0.08, with high estimates of -$0.06 and low estimates of -$0.09.
Analysts are recommending an EPS of between -$0.23 and -$0.36 for the fiscal current year, implying an average EPS of -$0.3. EPS for the following year is -$0.28, with 5 analysts recommending between -$0.23 and -$0.36.
